FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202608712> ?p ?o ?g. }

• W3202608712 endingPage "e0258255" @default.
• W3202608712 startingPage "e0258255" @default.
• W3202608712 abstract "This study aimed to assess the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) total antibodies in the north, middle, and south regions of West Bank and the prevalence of SARS-CoV-2 specific antibodies (IgA, IgM, and IgG) in the Palestinian population. This was a cross-sectional study. The serological and epidemiological data of 1269 persons were assessed. Participants were selected randomly among primary health care center attendees in Palestine between November 1, 2020 and December 31, 2020. All serum samples were tested for total antibodies using an enzyme-linked immunosorbent assay (ELISA) test. IgM, IgG, and IgA-specific antibody titers were measured using ELISA. The overall prevalence (with 95% confidence intervals [CIs]) of SARS-CoV-2 total antibodies and specific antibodies were estimated. A multivariate regression model was used to assess the predictive factors for SARS-CoV-2-specific antibodies. The overall seroprevalence of SARS-CoV-2 antibodies was 24·0% (95% CI, 21·7%-26·5%). Seroprevalence was significantly higher among people living in south West Bank (adjusted Odds ratio [aOR], 2·22; 95% CI: 1·58-3·11), people who had COVID-19 symptoms (aOR, 3·92; 95% CI, 2·83-5·43), people with a COVID-19 contact history (aOR, 1·44; 95% CI, 1·03-2·03), patients with hypertension (aOR, 1·57; 95% CI, 1·06-2·33), and non-smokers (aOR, 0·47; 95% CI, 0·31-0·72). A total of 171 blood samples from SARS-CoV-2-positive patients were chosen at random for additional serological testing. Specific IgM, IgG, and IgA antibodies were positive in 14·0% (95% CI, 9·2%-20·2%), 88·3% (82·5%-92·7%), and 42·1% (34·6%-59·9%) of the samples, respectively. SARS-CoV-2 antibodies were common among PHC center attendees and were significantly associated to sex, smoking, and COVID-19 contact history. However, considering that almost three-quarters of this population remains susceptible, maintaining public health measures and encouraging access to immunization is critical in protecting this population." @default.
• W3202608712 created "2021-10-11" @default.
• W3202608712 creator A5010197367 @default.
• W3202608712 creator A5032097306 @default.
• W3202608712 creator A5032116793 @default.
• W3202608712 creator A5046901717 @default.
• W3202608712 creator A5053954164 @default.
• W3202608712 creator A5056769885 @default.
• W3202608712 creator A5068844414 @default.
• W3202608712 creator A5086805786 @default.
• W3202608712 date "2021-10-08" @default.
• W3202608712 modified "2023-09-27" @default.
• W3202608712 title "Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study" @default.
• W3202608712 cites W2151461700 @default.
• W3202608712 cites W2152548537 @default.
• W3202608712 cites W2417415103 @default.
• W3202608712 cites W3001118548 @default.
• W3202608712 cites W3003668884 @default.
• W3202608712 cites W3004239190 @default.
• W3202608712 cites W3004412595 @default.
• W3202608712 cites W3012284084 @default.
• W3202608712 cites W3013985547 @default.
• W3202608712 cites W3022379136 @default.
• W3202608712 cites W3026545200 @default.
• W3202608712 cites W3036891376 @default.
• W3202608712 cites W3040552450 @default.
• W3202608712 cites W3041225163 @default.
• W3202608712 cites W3042194934 @default.
• W3202608712 cites W3043457217 @default.
• W3202608712 cites W3087128437 @default.
• W3202608712 cites W3087326888 @default.
• W3202608712 cites W3090667016 @default.
• W3202608712 cites W3093656234 @default.
• W3202608712 cites W3109360305 @default.
• W3202608712 cites W3111424223 @default.
• W3202608712 cites W3112389805 @default.
• W3202608712 cites W3165838540 @default.
• W3202608712 doi "https://doi.org/10.1371/journal.pone.0258255" @default.
• W3202608712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8500452" @default.
• W3202608712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34624024" @default.
• W3202608712 hasPublicationYear "2021" @default.
• W3202608712 type Work @default.
• W3202608712 sameAs 3202608712 @default.
• W3202608712 citedByCount "5" @default.
• W3202608712 countsByYear W32026087122022 @default.
• W3202608712 countsByYear W32026087122023 @default.
• W3202608712 crossrefType "journal-article" @default.
• W3202608712 hasAuthorship W3202608712A5010197367 @default.
• W3202608712 hasAuthorship W3202608712A5032097306 @default.
• W3202608712 hasAuthorship W3202608712A5032116793 @default.
• W3202608712 hasAuthorship W3202608712A5046901717 @default.
• W3202608712 hasAuthorship W3202608712A5053954164 @default.
• W3202608712 hasAuthorship W3202608712A5056769885 @default.
• W3202608712 hasAuthorship W3202608712A5068844414 @default.
• W3202608712 hasAuthorship W3202608712A5086805786 @default.
• W3202608712 hasBestOaLocation W32026087121 @default.
• W3202608712 hasConcept C107130276 @default.
• W3202608712 hasConcept C126322002 @default.
• W3202608712 hasConcept C142052008 @default.
• W3202608712 hasConcept C142724271 @default.
• W3202608712 hasConcept C156957248 @default.
• W3202608712 hasConcept C159654299 @default.
• W3202608712 hasConcept C203014093 @default.
• W3202608712 hasConcept C2778494684 @default.
• W3202608712 hasConcept C2908647359 @default.
• W3202608712 hasConcept C44249647 @default.
• W3202608712 hasConcept C45189115 @default.
• W3202608712 hasConcept C71924100 @default.
• W3202608712 hasConcept C99454951 @default.
• W3202608712 hasConceptScore W3202608712C107130276 @default.
• W3202608712 hasConceptScore W3202608712C126322002 @default.
• W3202608712 hasConceptScore W3202608712C142052008 @default.
• W3202608712 hasConceptScore W3202608712C142724271 @default.
• W3202608712 hasConceptScore W3202608712C156957248 @default.
• W3202608712 hasConceptScore W3202608712C159654299 @default.
• W3202608712 hasConceptScore W3202608712C203014093 @default.
• W3202608712 hasConceptScore W3202608712C2778494684 @default.
• W3202608712 hasConceptScore W3202608712C2908647359 @default.
• W3202608712 hasConceptScore W3202608712C44249647 @default.
• W3202608712 hasConceptScore W3202608712C45189115 @default.
• W3202608712 hasConceptScore W3202608712C71924100 @default.
• W3202608712 hasConceptScore W3202608712C99454951 @default.
• W3202608712 hasIssue "10" @default.
• W3202608712 hasLocation W32026087121 @default.
• W3202608712 hasLocation W32026087122 @default.
• W3202608712 hasLocation W32026087123 @default.
• W3202608712 hasLocation W32026087124 @default.
• W3202608712 hasOpenAccess W3202608712 @default.
• W3202608712 hasPrimaryLocation W32026087121 @default.
• W3202608712 hasRelatedWork W149992647 @default.
• W3202608712 hasRelatedWork W2000020394 @default.
• W3202608712 hasRelatedWork W2016667107 @default.
• W3202608712 hasRelatedWork W2328253637 @default.
• W3202608712 hasRelatedWork W2336753954 @default.
• W3202608712 hasRelatedWork W3025588727 @default.
• W3202608712 hasRelatedWork W3116800035 @default.
• W3202608712 hasRelatedWork W3136483994 @default.
• W3202608712 hasRelatedWork W4281940737 @default.

• next